Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Pharmaceuticals, patients and politics: How has New Zealand got so far behind with medicines?
+Print Archive
Etcetera
Pharmaceuticals, patients and politics: How has New Zealand got so far behind with medicines?
Wednesday 14 April 2021, 12:50 AM

New Zealand takes 2.5 times the OECD average of nine months, to publicly fund modern medicines. Why the delay here? Asks Medicines New Zealand chief Graeme Jarvis
VIEWPOINT
Graeme Jarvis has some questions for the reviewers of funding agency Pharmac to ask as they embark on their work
The Government’s decision to have a review into drug funder Pharmac should be seen both as positive and as good public-sector governance.
This, of
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.